Summary of Product Characteristics
last updated on the eMC:
15/09/2005
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15/09/2005 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 11/06/2003 and displayed until 15/09/2005
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 26/11/2002 and displayed until 11/06/2003
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
|
|
Updated on 13/08/2001 and displayed until 26/11/2002
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|